Oral azathioprine for recalcitrant pediatric atopic dermatitis: Clinical response and thiopurine monitoring

Journal of the American Academy of Dermatology

Volumn 68, Issue 1, 2013, Pages 29-35

  Caufield, Maura ^a   Tom, Wynnis L ^b,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

atopic dermatitis; azathioprine; eczema; monitoring; pediatric; thiopurine metabolites; thiopurine methyltransferase

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; 6 METHYLTHIOINOSINE; 6 THIOGUANINE NUCLEOTIDE; AZATHIOPRINE; CYCLOSPORIN; PREDNISONE; THIOPURINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE SIZE; SCHOOL CHILD; SIDE EFFECT; TREATMENT RESPONSE;

6-MERCAPTOPURINE; ADMINISTRATION, ORAL; ADOLESCENT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; GUANINE NUCLEOTIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLTRANSFERASES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THIONUCLEOTIDES;

EID: 84870873547     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.07.001     Document Type: Article

References (19)

1. E.L. Simpson, and J.M. Hanifin Atopic dermatitis Med Clin North Am 90 2006 149 167
2. S.J. Meggitt, J.C. Gray, and N.J. Reynolds Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial Lancet 367 2006 839 846
3. J. Berth-Jones, A. Takwale, E. Tan, G. Barclay, S. Agarwal, and I. Ahmed Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial Br J Dermatol 147 2002 324 330
4. L.A. Murphy, and D. Atherton A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression Br J Dermatol 147 2002 308 315
5. K.L. Hon, G.K. Ching, T.F. Leung, C.M. Chow, K.K. Lee, and P.C. Ng Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults J Dermatolog Treat 20 2009 141 145
6. W.T. Waxweiler, R. Agans, and D.S. Morrell Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil Pediatr Dermatol 28 2011 689 694
7. A.A. Patel, R.A. Swerlick, and C.O. McCall Azathioprine in dermatology: the past, the present, and the future J Am Acad Dermatol 55 2006 369 389
8. R.A. el-Azhary, S.A. Farmer, L.A. Drage, R.S. Rogers III, M.T. McEvoy, and M.D. Davis Thioguanine nucleotides and thiopurine methyltransferase in immunobullous diseases: optimal levels as adjunctive tools for azathioprine monitoring Arch Dermatol 145 2009 644 652
9. J. Mircheva, C. Legendre, C. Soria-Royer, E. Thervet, P. Beaune, and H. Kreis Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients Transplantation 60 1995 639 642
10. M.L. Appell, P. Wennerstrand, C. Peterson, E. Hertervig, and L.G. Mårtensson Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene Pharmacogenet Genomics 20 2010 700 707
11. J. Landy, N. Bhuva, A. Marinaki, and J. Mawdsley Novel thiopurine methyltransferase variant TPMT*28 results in a misdiagnosis of TPMT deficiency Inflamm Bowel Dis 17 2011 1441 1442
12. A. Firooz, N. Ghandi, Z. Hallaji, C. Chams-Davatchi, M. Valikhani, and M. Karbakhsh Davari Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris Arch Dermatol 144 2008 1143 1147
13. L.A. Murphy, and D.J. Atherton Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency Pediatr Dermatol 20 2003 531 534
14. M. Lindqvist, U. Hindorf, S. Almer, P. Söderkvist, M. Ström, and H. Hjortswang No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease Nucleosides Nucleotides Nucleic Acids 25 2006 1033 1037
15. K. Dilger, E. Schaeffeler, M. Lukas, U. Strauch, H. Herfarth, and R. Müller Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine Ther Drug Monit 29 2007 1 5
16. J.P. Gisbert, M. Chaparro, and F. Gomollón Common misconceptions about 5-Aminosalicylates and thiopurines in inflammatory bowel disease World J Gastroenterol 17 2011 3467 3478
17. S.J. Meggitt, A.V. Anstey, M.F. Mohd Mustapa, N.J. Reynolds, and S. Wakelin British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011 Br J Dermatol 165 2011 711 734
18. M.C. Dubinsky, S. Lamothe, H.Y. Yang, S.R. Targan, D. Sinnett, and Y. Théorêt Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease Gastroenterology 118 2000 705 713
19. A.D. Askanase, D.J. Wallace, M.H. Weisman, C.E. Tseng, L. Bernstein, and H.M. Belmont Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus J Rheumatol 36 2009 89 95